The Catalyst Program is UCSF’s translational accelerator focused on advancing UCSF discoveries with clinical impact and commercial potential. The centerpiece of the Catalyst Program are Catalyst Awards that provide both industry advisor mentorship and seed funding to UCSF PIs with promising projects. The Catalyst Awards are focused on the development of therapeutics, diagnostics, medical devices and digital health. Previous Catalyst Awardees include UCSF investigators whose works span a broad range of innovative concepts. The mentorship and funding awardees received enabled them to reach key milestones along the development path towards safe and effective solutions for patients.
ShangPharma Awards for the Development of Therapeutics
UCSF has a collaboration with ShangPharma Innovation to progress therapeutics projects towards the clinic. This collaboration, managed by the Catalyst Program, includes both direct project funding and contract research services provided by ChemPartner.
Therapeutics - if chosen for a collaboration with ShangPharma Innovation, a project can qualify for funding of up to ~$400K/year together plus up to ~$600K/year in CRO services at ChemPartner. If chosen for UCSF Catalyst Award funding the maximum award is $100K
Diagnostics - up to $100K
Medical Devices - up to $100K
Digital Health - up to $50K
Monday, September 23, 2019 to 2:00pm